Walgreens Pain Relieving Plus Turmeric Analgesic
Trolamine Salicylate
Walgreen Company
Human Otc Drug
NDC 0363-3630Walgreens Pain Relieving Plus Turmeric Analgesic also known as Trolamine Salicylate is a human otc drug labeled by 'Walgreen Company'. National Drug Code (NDC) number for Walgreens Pain Relieving Plus Turmeric Analgesic is 0363-3630. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Walgreens Pain Relieving Plus Turmeric Analgesic drug includes Trolamine Salicylate - 100 mg/g . The currest status of Walgreens Pain Relieving Plus Turmeric Analgesic drug is Active.
Drug Information:
| Drug NDC: | 0363-3630 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Walgreens Pain Relieving Plus Turmeric Analgesic |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Proprietary Name Base: | Walgreens Pain Relieving Plus Turmeric |
| The base of the Brand/Proprietary name excluding its suffix. |
| Proprietary Name Suffix: | Analgesic |
| A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Trolamine Salicylate |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Walgreen Company |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | TROLAMINE SALICYLATE - 100 mg/g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 22 Jun, 2021 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 15 Jan, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part348 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Walgreen Company
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 313518
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | H8O4040BHD
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 0363-3630-01 | 1 TUBE in 1 CARTON (0363-3630-01) / 113 g in 1 TUBE | 22 Jun, 2021 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose topical analgesic
Product Elements:
Walgreens pain relieving plus turmeric analgesic trolamine salicylate trolamine salicylate salicylic acid carbomer interpolymer type a (allyl sucrose crosslinked) arnica montana flower frankincense oil shea butter tamanu oil medium-chain triglycerides cetyl alcohol turmeric ethylhexylglycerin glycerin glyceryl monostearate harpagophytum procumbens root isopropyl palmitate macadamia oil menthol, unspecified form olive oil peg-100 stearate phenoxyethanol propylene glycol salix alba bark hyaluronate sodium sodium hydroxide sodium pyrrolidone carboxylate stearic acid cocoa butter water
Indications and Usage:
Uses for the temporarily relief of minor aches and pains of muscles and joint associated with: ? simple backache ? arthritis ? strains ? bruises ? sprains
Warnings:
Warnings for external use only allergy alert: if prone to allergic reaction from aspirin or salicylates, consult a doctor before use. when using this product ? avoid contact with eyes ? do not apply to wounds or damaged skin ? do not bandage tightly ? do not use with heating pads or heating devices ? if condition worsens, or if the symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor ? avoid contact with the eyes and mucous membranes if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children . if swallowed, get medical help or contact a poison control center (1-800-222-1222) right away.
When Using:
When using this product ? avoid contact with eyes ? do not apply to wounds or damaged skin ? do not bandage tightly ? do not use with heating pads or heating devices ? if condition worsens, or if the symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor ? avoid contact with the eyes and mucous membranes
Dosage and Administration:
Directions adults and children 12 years of age and older apply to affected area not more than 3 to 4 times daily. children under 12 years of age: do not use.
Package Label Principal Display Panel:
Principal display panel - 113 g tube carton walgreens walgreens pharmacist recommended pain relieving cream + turmeric trolamine salicylate 10% / topical analgesic with turmeric, boswellia, tamanu oil & devil's claw paraben free helps relieve minor aches & pains of muscles & joints associated with simple backache, arthritis, strains, bruises & sprains net wt 4 oz (113 g) principal display panel - 113 g tube carton
Further Questions:
Questions or comments? 1-800-925-4733